Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma (Cancer Immunology, Immunotherapy, (2021), 70, 7, (1965-1976), 10.1007/s00262-020-02820-4)

Pedro Rocha, Ruth Salazar, Jiexin Zhang, Debora Ledesma, Jose L. Solorzano, Barbara Mino, Pamela Villalobos, Hitoshi Dejima, Dzifa Y. Douse, Lixia Diao, Kyle Gregory Mitchell, Xiuning Le, Jianjun Zhang, Annikka Weissferdt, Edwin Parra-Cuentas, Tina Cascone, David C. Rice, Boris Sepesi, Neda Kalhor, Cesar MoranAra Vaporciyan, John Heymach, Don L. Gibbons, J. Jack Lee, Humam Kadara, Ignacio Wistuba, Carmen Behrens, Luisa Maren Solis

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original version of this article unfortunately contained a mistake. The presentation of Fig. 2 was incorrect. The corrected Fig. 2 is given in following page. The original article has been corrected. (Figure presented.).

Original languageEnglish (US)
Pages (from-to)1977-1978
Number of pages2
JournalCancer Immunology, Immunotherapy
Volume70
Issue number7
DOIs
StatePublished - Jul 2021

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma (Cancer Immunology, Immunotherapy, (2021), 70, 7, (1965-1976), 10.1007/s00262-020-02820-4)'. Together they form a unique fingerprint.

Cite this